How COVID-19 is Changing Biologic Workspaces
SAN DIEGO – The past four days, hundreds of keynote speakers in academia, biotech, and pharma virtually gathered for the Festival of Biologics.
Unlike other years, many of the top-producers in the biopharma and life sciences industries discussed how work practices have changed as a result of the COVID-19 crisis.
Chris McPherson, a senior scientist at Samsung Biologics, described how in only three months his company was able to manufacture and deliver drugs in light of what he called the “black swan,” or unpredictable event.
McPherson explained that a typical technology transfer timeline takes 12 months, starting from the project kick off, to engineering run, to the clinical run. But his team was able to expedite that timeline to three months.
Using four case studies, McPherson illustrated that when his lab experienced supply issues from a shortage of raw material availability, that they were able to resolve the issue by, “leveraging Samsung’s biologics plants at one time.”
Gimbal-mounted, high-definition cameras, allowed for things such as virtual meetings, data sharing, and client access for audits and tours inside the lab. The cameras allowed McPherson and his team to zoom in and out of various pieces of equipment to show what was happening on the ground floor during a time his clients could not physically be there.
Mcpherson said these improvements in manufacturing and delivering drugs won’t just happen because of COVID-19 but are sustainable long-term.
The year 2020 also galvanized efforts to increase diversity, equity, and inclusion in the workplace, as biopharma and life science CEOs looked to providing more roles for women and other underrepresented populations.
“A lot of companies have gender balance at about 50/50, but when you look at senior roles you see less women represented, and the same is true of diversity as well,” stated Rebecca Sendak, the head of Global Large Molecules Research Platform at Sanofi.
“2020 was a powerful year for our company,” explained Kristen Hege, senior vice president in Early Clinical Development in Hematology and Oncology at Bristol-Myers Squibb.
Hege explained that her CEO Giovanni Caforio made a public commitment of $3 million over the next five years to expand health equity and diversity and inclusion efforts, like increasing supplier diversity with Black, African American owned businesses.
“We trained 250 new racially and ethnically diverse clinical investigators, understanding that to enroll more diverse patients in clinical trials we need more investigators that connect at a personal level with those patients,” stated Hege.
Other female panelists discussed changes in workspaces such as having “equity audits,” to interrogate policies and practices which don’t align with equity and inclusivity values.
“I think the George Floyd murder woke a lot of people up and having that graphically captured struck a chord. When those events unfolded, there were people who wanted to talk about it. We scheduled events and brought in guest speakers to talk about things that were once taboo to talk about. We saw a shift from 2020 in that regard,” stated Sendak.
In The News
WASHINGTON (AP) — U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson's single-shot COVID-19 vaccine... Read More
WASHINGTON (AP) — U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when — and whether using a competing brand for the second dose might provide better protection. The push for boosters kicked off last month after... Read More
U.S. health advisers said Thursday that some Americans who received Moderna's COVID-19 vaccine should get a half-dose booster to bolster... Read More
U.S. health advisers said Thursday that some Americans who received Moderna's COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other... Read More
STORRS, Conn. (AP) — Nurses around the U.S. are getting burned out by the COVID-19 crisis and quitting, yet applications... Read More
STORRS, Conn. (AP) — Nurses around the U.S. are getting burned out by the COVID-19 crisis and quitting, yet applications to nursing schools are rising, driven by what educators say are young people who see the global emergency as an opportunity and a challenge. Among them... Read More
NEW YORK (AP) — Food companies are coming under renewed pressure to use less salt after U.S. regulators spelled out... Read More
NEW YORK (AP) — Food companies are coming under renewed pressure to use less salt after U.S. regulators spelled out long-awaited guidelines aimed at reducing sodium levels in dozens of foods including condiments, cereals, french fries and potato chips. The voluntary goals finalized Wednesday for 163... Read More
WASHINGTON — New data presented by researchers from Editas Medicine, a leading genome editing company, reveals that gene editing treatments... Read More
WASHINGTON — New data presented by researchers from Editas Medicine, a leading genome editing company, reveals that gene editing treatments are not only safe in humans, but may hold promise of treating a rare retinal disease that leads to blindness. “We believe these findings validate the... Read More
WASHINGTON -- The COVID-19 pandemic has impacted veterans' access to food, leading to greater food insecurity, and according to officials... Read More
WASHINGTON -- The COVID-19 pandemic has impacted veterans' access to food, leading to greater food insecurity, and according to officials from the United States Department of Veterans Affairs, telehealth is now helping to combat the issue. “The COVID-19 pandemic certainly has been impactful for many Americans,... Read More